These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

499 related items for PubMed ID: 17335886

  • 1. Recombinant allergens for immunotherapy.
    Valenta R, Niederberger V.
    J Allergy Clin Immunol; 2007 Apr; 119(4):826-30. PubMed ID: 17335886
    [Abstract] [Full Text] [Related]

  • 2. Recombinant allergens for specific immunotherapy.
    Cromwell O, Häfner D, Nandy A.
    J Allergy Clin Immunol; 2011 Apr; 127(4):865-72. PubMed ID: 21377719
    [Abstract] [Full Text] [Related]

  • 3. A hypoallergenic hybrid molecule with increased immunogenicity consisting of derivatives of the major grass pollen allergens, Phl p 2 and Phl p 6.
    Linhart B, Mothes-Luksch N, Vrtala S, Kneidinger M, Valent P, Valenta R.
    Biol Chem; 2008 Jul; 389(7):925-33. PubMed ID: 18627317
    [Abstract] [Full Text] [Related]

  • 4. Strategies for converting allergens into hypoallergenic vaccine candidates.
    Vrtala S, Focke-Tejkl M, Swoboda I, Kraft D, Valenta R.
    Methods; 2004 Mar; 32(3):313-20. PubMed ID: 14962766
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis.
    Pauli G, Larsen TH, Rak S, Horak F, Pastorello E, Valenta R, Purohit A, Arvidsson M, Kavina A, Schroeder JW, Mothes N, Spitzauer S, Montagut A, Galvain S, Melac M, André C, Poulsen LK, Malling HJ.
    J Allergy Clin Immunol; 2008 Nov; 122(5):951-60. PubMed ID: 19000581
    [Abstract] [Full Text] [Related]

  • 6. Allergy diagnosis, allergen repertoires, and their implications for allergen-specific immunotherapy.
    Crameri R.
    Immunol Allergy Clin North Am; 2006 May; 26(2):179-89, v. PubMed ID: 16701139
    [Abstract] [Full Text] [Related]

  • 7. Genetic allergen modification in the development of novel approaches to specific immunotherapy.
    Mutschlechner S, Deifl S, Bohle B.
    Clin Exp Allergy; 2009 Nov; 39(11):1635-42. PubMed ID: 19624521
    [Abstract] [Full Text] [Related]

  • 8. The current state of recombinant allergens for immunotherapy.
    Pauli G, Malling HJ.
    Curr Opin Allergy Clin Immunol; 2010 Dec; 10(6):575-81. PubMed ID: 20859201
    [Abstract] [Full Text] [Related]

  • 9. Recombinant allergens for allergen-specific immunotherapy: 10 years anniversary of immunotherapy with recombinant allergens.
    Valenta R, Linhart B, Swoboda I, Niederberger V.
    Allergy; 2011 Jun; 66(6):775-83. PubMed ID: 21352238
    [Abstract] [Full Text] [Related]

  • 10. Recombinant allergens for pollen immunotherapy.
    Wallner M, Pichler U, Ferreira F.
    Immunotherapy; 2013 Dec; 5(12):1323-38. PubMed ID: 24283843
    [Abstract] [Full Text] [Related]

  • 11. [Diagnostic and therapeutic value of synthetic or recombinant allergens].
    Spertini F.
    Rev Med Suisse Romande; 1999 Mar; 119(3):235-9. PubMed ID: 10218421
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Reducing allergenicity by altering allergen fold: a mosaic protein of Phl p 1 for allergy vaccination.
    Ball T, Linhart B, Sonneck K, Blatt K, Herrmann H, Valent P, Stoecklinger A, Lupinek C, Thalhamer J, Fedorov AA, Almo SC, Valenta R.
    Allergy; 2009 Apr; 64(4):569-80. PubMed ID: 19243361
    [Abstract] [Full Text] [Related]

  • 14. Characterization of a hypoallergenic recombinant Bet v 1 variant as a candidate for allergen-specific immunotherapy.
    Kahlert H, Suck R, Weber B, Nandy A, Wald M, Keller W, Cromwell O, Fiebig H.
    Int Arch Allergy Immunol; 2008 Apr; 145(3):193-206. PubMed ID: 17912007
    [Abstract] [Full Text] [Related]

  • 15. [Recombinant allergens; allergy vaccine in the future?. Interview by Dr. Barbara Scholtissek].
    Valenta R.
    Wien Med Wochenschr; 1999 Apr; 149(14-15):450-1. PubMed ID: 10584293
    [No Abstract] [Full Text] [Related]

  • 16. Genetic engineering of pollen allergens for hayfever immunotherapy.
    Bhalla PL.
    Expert Rev Vaccines; 2003 Feb; 2(1):75-84. PubMed ID: 12901599
    [Abstract] [Full Text] [Related]

  • 17. From allergen genes to new forms of allergy diagnosis and treatment.
    Vrtala S.
    Allergy; 2008 Mar; 63(3):299-309. PubMed ID: 18269675
    [Abstract] [Full Text] [Related]

  • 18. Molecular approaches for new vaccines against allergy.
    Niederberger V, Valenta R.
    Expert Rev Vaccines; 2006 Feb; 5(1):103-10. PubMed ID: 16451112
    [Abstract] [Full Text] [Related]

  • 19. The future of antigen-specific immunotherapy of allergy.
    Valenta R.
    Nat Rev Immunol; 2002 Jun; 2(6):446-53. PubMed ID: 12093011
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.